15 results
Antiarrhythmics - Vaughan Williams Classification
Class I (Ia, Ib, Ic) - Na+ Channel Blockade
 • Slows depolarization
Antiarrhythmics - Vaughan ... Classification Class I (Ia, Ib ... Classification #Classes #cardiology ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicillium marneffei Infections ... itraconazolea 200 mg PO BID ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... mg) PO (or IV) BID ... 160 mg/800 mg) BID ... IsosporaBelli #IDSA ... #HIVAIDS #pharmacology
Antiarrhythmic Medications - Vaughan-Williams Classification
 • Class I (Ia, Ib, Ic)
 • Class II
 • Class
Medications - Vaughan-Williams ... • Class I (Ia, Ib ... #Medications #Vaughan ... Classification #pharmacology ... #cardiology
Antiarrhythmic Medications - Vaughan-Williams Classification
 • Class I (Ia, Ib, Ic)
 • Class II
 • Class
Medications - Vaughan-Williams ... • Class I (Ia, Ib ... #Medications #Vaughan ... Classification #pharmacology ... #cardiology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... candida #mucosal #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Simplex Virus (HSV) Infections ... HerpesSimplex #HSV #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Clostridium difficile infection ... Fidaxomicin - 200 mg PO bid ... 50 mg IV every bid ... treatment #management #pharmacology ... #idsa #table
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... control of the infection ... Valganciclovir 900 mg PO BID ... Cytomegalovirus #CMV #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
IDSA Recommendations ... Treponema pallidum Infections ... Treponema #pallidum #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology